Molecular mechanisms of pancreatic cancer and potential targets of treatment

By Aho Ursula   Zhao Xia   Löhr Matthias   Andersson Roland  

Scandinavian Journal of Gastroenterology, Vol. 42, Iss. 3, 2007-01 ,pp. : 279-296

Informa Healthcare

Access to resources Recommend Favorite

Progesterone-induced secretion of growth hormone, insulin-like growth factor I and prolactin by human breast cancer explants

By Gregoraszczuk E. L.   Milewicz T.   Kolodziejczyk J.   Krzysiek J.   Basta A.   Sztefko K.   Kurek S.   Stachura J.  

Gynecological Endocrinology, Vol. 15, Iss. 4, 2001-08 ,pp. : 251-258

Informa Healthcare

Access to resources Recommend Favorite

Molecular markers for predicting response to tamoxifen in breast cancer patients

By Ciocca Daniel   Elledge Richard  

Endocrine Journal, Vol. 13, Iss. 1, 2000-08 ,pp. : 1-10

Humana Press, Inc

Access to resources Recommend Favorite

Combined treatment with biphosphonates, low-dose chemotherapy, and trastuzumab in receptor-negative breast cancer patients with bone marrow involvement

By Bezares S.   Amador M.L.   Castellano D.   Trigo J.M.   Cortes-Funes H.   Colomer R.  

European Journal of Internal Medicine, Vol. 12, Iss. 5, 2001-09 ,pp. : 462-463

Elsevier

Access to resources Recommend Favorite

Prolactin as an autocrine/paracrine growth factor in human cancer

By Ben-Jonathan N.   Liby K.   McFarland M.   Zinger M.  

Trends in Endocrinology and Metabolism, Vol. 13, Iss. 6, 2002-08 ,pp. : 245-250

Elsevier

Access to resources Recommend Favorite